Agents for influenza neutralization

1. A method of treating a subject, the method comprising steps of:

administering to a subject suffering from or susceptible to influenza infection a therapeutically effective amount of an antibody that comprises a heavy chain having an amino acid sequence that is at least 95% identical to SEQ ID NO:1 and a light chain having an amino acid sequence that is at least 95% identical to one of SEQ ID NOs:33-43.

2. The method of claim 1 , wherein the antibody is formulated for administration by a route selected from the group consisting of oral, intravenous, intramuscular, intra-arterial, subcutaneous, intraventricular, transdermal, interdermal, rectal, intravaginal, intraperitoneal, topical, mucosal, nasal, buccal, enteral, sublingual, intratracheal or bronchial.

3. The method of claim 2 , wherein the administration is by intratracheal or bronchial instillation.

4. The method of claim 2 , wherein the administration is by inhalation.

5. The method of claim 1 , wherein the antibody is formulated as an oral spray, a nasal spray, or an aerosol.

6. A method of detecting a hemagglutinin (HA) polypeptide in a sample, the method comprising steps of:

contacting a sample with an antibody that comprises a heavy chain having an amino acid sequence that is at least 95% identical to SEQ ID NO:1 and a light chain having an amino acid sequence that is at least 95% identical to one of SEQ ID NO:33-43; and

detecting binding in the sample.

7. The method of claim 6 , wherein the sample is or comprises one or more of blood, serum/plasma, peripheral blood mononuclear cells/peripheral blood lymphocytes (PBMC/PBL), sputum, urine, feces, throat swabs, dermal lesion swabs, cerebrospinal fluids, cervical smears, pus samples, food matrices, and tissues from various parts of the body such as brain, spleen, and liver.

8. The method of 6 , wherein the sample is an environmental sample.

9. The method of claim 8 , wherein the environmental sample is or comprises one or more of soil, water and flora.